GLAXOSMITHKLINE LLC FDA Approval NDA 020241

NDA 020241

GLAXOSMITHKLINE LLC

FDA Drug Application

Application #020241

Documents

Letter1998-12-14
Letter2004-01-22
Letter2013-09-06
Letter2013-09-06
Letter2013-09-06
Letter2013-12-26
Letter2010-11-03
Letter2015-03-25
Letter2011-06-02
Letter2015-03-25
Label1998-08-24
Label2006-09-26
Label2013-09-06
Label2013-09-06
Label2013-09-06
Label2015-01-05
Label2009-05-12
Label2010-10-28
Label2015-03-25
Label2015-03-25
Label2015-05-21
Review1999-06-30
Letter1998-08-24
Letter2006-09-27
Letter2003-07-06
Letter2003-04-18
Letter2013-09-06
Letter2015-01-07
Letter2009-05-13
Letter2009-05-04
Letter2009-05-04
Letter2015-01-07
Letter2010-11-03
Letter2011-08-08
Letter2011-12-02
Letter2012-08-02
Letter2014-06-12
Letter2015-05-20
Label1998-12-14
Label2003-03-06
Label2006-09-25
Label2001-05-25
Label2003-07-08
Label2013-09-06
Label2009-07-08
Label2009-05-12
Label2013-12-23
Label2015-01-05
Label2010-10-28
Label2011-08-05
Label2011-12-02
Label2012-08-02
Label2014-06-30
Review1999-05-20
Review2005-12-08
Review2007-05-29
Review2013-09-06
Label2018-07-05
Letter2018-07-06
Letter2018-07-24
Label2018-07-26
Letter2019-08-15
Label2019-08-15
Letter2019-09-26
Label2019-09-26
Medication Guide2019-09-26
Pediatric Medical Review1900-01-01
Pediatric Clinical Pharmacology Review1900-01-01
Pediatric Written Request1900-01-01
Letter2020-08-19
Letter2020-09-01
Label2020-09-04
Medication Guide2020-09-04
Pediatric Medical Review1900-01-01
Label2020-09-11
Medication Guide2020-09-11
Letter2020-09-11
Letter2020-10-14
Label2020-10-14
Medication Guide2020-10-14
Letter2021-04-01
Label2021-04-01
Medication Guide2021-04-01

Application Sponsors

NDA 020241GLAXOSMITHKLINE LLC

Marketing Status

Prescription001
Prescription002
Prescription003
Discontinued004
Prescription005
Discontinued006

Application Products

001TABLET;ORAL100MG1LAMICTALLAMOTRIGINE
002TABLET;ORAL150MG1LAMICTALLAMOTRIGINE
003TABLET;ORAL200MG1LAMICTALLAMOTRIGINE
004TABLET;ORAL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1LAMICTALLAMOTRIGINE
005TABLET;ORAL25MG1LAMICTALLAMOTRIGINE
006TABLET;ORAL50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1LAMICTALLAMOTRIGINE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1994-12-27PRIORITY
EFFICACY; EfficacySUPPL2AP1998-08-24STANDARD
EFFICACY; EfficacySUPPL3AP1998-12-14STANDARD
LABELING; LabelingSUPPL4AP1997-03-11STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1998-03-16PRIORITY
LABELING; LabelingSUPPL6AP1998-03-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1999-05-10PRIORITY
EFFICACY; EfficacySUPPL8AP2003-01-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1999-06-08PRIORITY
LABELING; LabelingSUPPL10AP2006-09-25STANDARD
EFFICACY; EfficacySUPPL11AP2001-05-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL12AP2000-06-12PRIORITY
LABELING; LabelingSUPPL14AP2000-09-08STANDARD
LABELING; LabelingSUPPL15AP2001-02-23STANDARD
EFFICACY; EfficacySUPPL16AP2004-01-14STANDARD
EFFICACY; EfficacySUPPL17AP2003-06-20STANDARD
LABELING; LabelingSUPPL18AP2003-04-04STANDARD
LABELING; LabelingSUPPL21AP2006-09-25STANDARD
LABELING; LabelingSUPPL25AP2006-09-25STANDARD
LABELING; LabelingSUPPL26AP2006-09-25STANDARD
EFFICACY; EfficacySUPPL27AP2006-09-22STANDARD
LABELING; LabelingSUPPL29AP2006-03-17STANDARD
LABELING; LabelingSUPPL35AP2014-12-30STANDARD
LABELING; LabelingSUPPL36AP2009-05-08STANDARD
LABELING; LabelingSUPPL37AP2009-04-23901 REQUIRED
LABELING; LabelingSUPPL38AP2009-04-23STANDARD
LABELING; LabelingSUPPL39AP2013-12-20UNKNOWN
LABELING; LabelingSUPPL40AP2014-12-30UNKNOWN
REMS; REMSSUPPL43AP2010-10-24N/A
LABELING; LabelingSUPPL44AP2010-10-24UNKNOWN
LABELING; LabelingSUPPL45AP2015-03-24STANDARD
LABELING; LabelingSUPPL47AP2011-08-04UNKNOWN
REMS; REMSSUPPL48AP2011-05-31N/A
LABELING; LabelingSUPPL49AP2011-11-29UNKNOWN
LABELING; LabelingSUPPL50AP2012-08-01UNKNOWN
LABELING; LabelingSUPPL51AP2015-03-24STANDARD
LABELING; LabelingSUPPL52AP2014-06-10STANDARD
EFFICACY; EfficacySUPPL53AP2015-05-18STANDARD
LABELING; LabelingSUPPL56AP2018-07-23STANDARD
LABELING; LabelingSUPPL57AP2018-06-27STANDARD
LABELING; LabelingSUPPL58AP2020-10-09STANDARD
LABELING; LabelingSUPPL59AP2019-08-14STANDARD
LABELING; LabelingSUPPL60AP2019-09-25STANDARD
LABELING; LabelingSUPPL61AP2020-08-19STANDARD
LABELING; LabelingSUPPL62AP2020-08-31STANDARD
LABELING; LabelingSUPPL64AP2021-03-31STANDARD

Submissions Property Types

SUPPL5Null0
SUPPL7Null0
SUPPL9Null0
SUPPL12Null0
SUPPL35Null6
SUPPL38Null7
SUPPL39Null6
SUPPL40Null6
SUPPL43Null6
SUPPL44Null6
SUPPL45Null6
SUPPL47Null6
SUPPL48Null6
SUPPL49Null6
SUPPL50Null6
SUPPL51Null7
SUPPL52Null7
SUPPL53Null15
SUPPL56Null7
SUPPL57Null7
SUPPL58Null15
SUPPL59Null7
SUPPL60Null7
SUPPL61Null15
SUPPL62Null7
SUPPL64Null7

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB
005PrescriptionAB

CDER Filings

GLAXOSMITHKLINE LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20241
            [companyName] => GLAXOSMITHKLINE LLC
            [docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/020241s060,020764s053,022251s024lbl.pdf#page=64"]
            [products] => [{"drugName":"LAMICTAL","activeIngredients":"LAMOTRIGINE","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"LAMICTAL","activeIngredients":"LAMOTRIGINE","strength":"150MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"LAMICTAL","activeIngredients":"LAMOTRIGINE","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"LAMICTAL","activeIngredients":"LAMOTRIGINE","strength":"250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"LAMICTAL","activeIngredients":"LAMOTRIGINE","strength":"25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"},{"drugName":"LAMICTAL","activeIngredients":"LAMOTRIGINE","strength":"50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"09\/25\/2019","submission":"SUPPL-60","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/020241s060,020764s053,022251s024lbl.pdf\"}]","notes":""},{"actionDate":"08\/14\/2019","submission":"SUPPL-59","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/020241s059,020764s052,022251s023lbl.pdf\"}]","notes":""},{"actionDate":"07\/23\/2018","submission":"SUPPL-56","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/020241s056,020764s049,022251s020lbl.pdf\"}]","notes":""},{"actionDate":"06\/27\/2018","submission":"SUPPL-57","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/020241s057lbl.pdf\"}]","notes":""},{"actionDate":"05\/18\/2015","submission":"SUPPL-53","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/020241s053,020764s046,022251s017lbl.pdf\"}]","notes":""},{"actionDate":"03\/24\/2015","submission":"SUPPL-51","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/020241s045s051lbl.pdf\"}]","notes":""},{"actionDate":"03\/24\/2015","submission":"SUPPL-45","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/020241s045s051lbl.pdf\"}]","notes":""},{"actionDate":"12\/30\/2014","submission":"SUPPL-40","supplementCategories":"Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/020241s035s040,020764s028s033,022251s002s009lbl.pdf\"}]","notes":""},{"actionDate":"12\/30\/2014","submission":"SUPPL-35","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/020241s035s040,020764s028s033,022251s002s009lbl.pdf\"}]","notes":""},{"actionDate":"06\/10\/2014","submission":"SUPPL-52","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/020241Orig1s052,020764Orig1s045,022251Orig1s016Lbl.pdf\"}]","notes":""},{"actionDate":"12\/20\/2013","submission":"SUPPL-39","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/020241s039,020764s032,022251s001lbl.pdf\"}]","notes":""},{"actionDate":"08\/01\/2012","submission":"SUPPL-50","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/020241s050,020764s043,022251s013lbl.pdf\"}]","notes":""},{"actionDate":"11\/29\/2011","submission":"SUPPL-49","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020241s049,020764s042,022251s012lbl.pdf\"}]","notes":""},{"actionDate":"08\/04\/2011","submission":"SUPPL-47","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020241s047,020764s040,022251s010lbl.pdf\"}]","notes":""},{"actionDate":"10\/24\/2010","submission":"SUPPL-44","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/020241s043s044,020764s036s037,022251s005s006lbl.pdf\"}]","notes":""},{"actionDate":"10\/24\/2010","submission":"SUPPL-43","supplementCategories":"REMS-Proposal","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/020241s043s044,020764s036s037,022251s005s006lbl.pdf\"}]","notes":""},{"actionDate":"05\/08\/2009","submission":"SUPPL-36","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/022251,020764s029,020241s036lbl.pdf\"}]","notes":""},{"actionDate":"04\/23\/2009","submission":"SUPPL-38","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""},{"actionDate":"04\/23\/2009","submission":"SUPPL-38","supplementCategories":"REMS-Proposal","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""},{"actionDate":"04\/23\/2009","submission":"SUPPL-37","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/020241s037s038,020764s030s031lbl.pdf\"}]","notes":""},{"actionDate":"09\/25\/2006","submission":"SUPPL-26","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf\"}]","notes":""},{"actionDate":"09\/25\/2006","submission":"SUPPL-25","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020241SLRs10s21s25s26s27,020764SLRs3s14s18s19s20lbl.pdf\"}]","notes":""},{"actionDate":"09\/25\/2006","submission":"SUPPL-21","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf\"}]","notes":""},{"actionDate":"09\/25\/2006","submission":"SUPPL-10","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020241SLRs10s21s25s26s27,020764SLRs3s14s18s19s20lbl.pdf\"}]","notes":""},{"actionDate":"09\/25\/2006","submission":"SUPPL-10","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf\"}]","notes":""},{"actionDate":"09\/22\/2006","submission":"SUPPL-27","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf\"}]","notes":""},{"actionDate":"06\/20\/2003","submission":"SUPPL-17","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/20241se1-017,20764se1-011_lamictal_lbl.pdf\"}]","notes":""},{"actionDate":"01\/17\/2003","submission":"SUPPL-8","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/020241s008lbl.pdf\"}]","notes":""},{"actionDate":"05\/25\/2001","submission":"SUPPL-11","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/20764s5lbl.pdf\"}]","notes":""},{"actionDate":"12\/14\/1998","submission":"SUPPL-3","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/1998\\\/20241s03lbl.pdf\"}]","notes":""},{"actionDate":"08\/24\/1998","submission":"SUPPL-2","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/1998\\\/20241s2lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"LAMICTAL","submission":"LAMOTRIGINE","actionType":"100MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"LAMICTAL","submission":"LAMOTRIGINE","actionType":"150MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"LAMICTAL","submission":"LAMOTRIGINE","actionType":"200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"LAMICTAL","submission":"LAMOTRIGINE","actionType":"250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"LAMICTAL","submission":"LAMOTRIGINE","actionType":"25MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"LAMICTAL","submission":"LAMOTRIGINE","actionType":"50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2019-09-25
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.